These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10331734)

  • 41. [In vitro study on cross resistance of rifampin and rifapentine for Mycobacterium tuberculosis].
    Duanmu HJ; Liu YH; Jiang GL; Wang SM; Fu YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Mar; 28(3):192-4. PubMed ID: 15854417
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects.
    Christopher R; Covington P; Davenport M; Fleck P; Mekki QA; Wann ER; Karim A
    Clin Ther; 2008 Mar; 30(3):513-27. PubMed ID: 18405789
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Moxifloxacin population pharmacokinetics in patients with pulmonary tuberculosis and the effect of intermittent high-dose rifapentine.
    Zvada SP; Denti P; Geldenhuys H; Meredith S; van As D; Hatherill M; Hanekom W; Wiesner L; Simonsson US; Jindani A; Harrison T; McIlleron HM
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4471-3. PubMed ID: 22585223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physiologically Based Pharmacokinetic Model of Rifapentine and 25-Desacetyl Rifapentine Disposition in Humans.
    Zurlinden TJ; Eppers GJ; Reisfeld B
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4860-8. PubMed ID: 27270284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preliminary pharmacokinetic study of repeated doses of rifampin and rifapentine in guinea pigs.
    Dutta NK; Alsultan A; Peloquin CA; Karakousis PC
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1535-7. PubMed ID: 23295923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The WHO simplified study protocol in practice: investigation of combined formulations supplied by the WHO.
    Panchagnula R; Kaur KJ; Singh I; Kaul CL
    Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S336-42; discussion S351-2. PubMed ID: 10593714
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis?
    Alfarisi O; Alghamdi WA; Al-Shaer MH; Dooley KE; Peloquin CA
    Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1027-1036. PubMed ID: 28803492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteers.
    Dooley KE; Bliven-Sizemore EE; Weiner M; Lu Y; Nuermberger EL; Hubbard WC; Fuchs EJ; Melia MT; Burman WJ; Dorman SE
    Clin Pharmacol Ther; 2012 May; 91(5):881-8. PubMed ID: 22472995
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of rifapentine and rifampin in a rabbit model of tuberculosis and correlation with clinical trial data.
    Rifat D; Prideaux B; Savic RM; Urbanowski ME; Parsons TL; Luna B; Marzinke MA; Ordonez AA; DeMarco VP; Jain SK; Dartois V; Bishai WR; Dooley KE
    Sci Transl Med; 2018 Apr; 10(435):. PubMed ID: 29618565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single-dose intrapulmonary pharmacokinetics of rifapentine in normal subjects.
    Conte JE; Golden JA; McQuitty M; Kipps J; Lin ET; Zurlinden E
    Antimicrob Agents Chemother; 2000 Apr; 44(4):985-90. PubMed ID: 10722501
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice.
    Ji B; Truffot-Pernot C; Lacroix C; Raviglione MC; O'Brien RJ; Olliaro P; Roscigno G; Grosset J
    Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1541-6. PubMed ID: 8256897
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro evaluation of novel inhalable dry powders consisting of thioridazine and rifapentine for rapid tuberculosis treatment.
    Parumasivam T; Chan JG; Pang A; Quan DH; Triccas JA; Britton WJ; Chan HK
    Eur J Pharm Biopharm; 2016 Oct; 107():205-14. PubMed ID: 27422209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rifapentine--a long-acting rifamycin for tuberculosis.
    Med Lett Drugs Ther; 1999 Feb; 41(1047):21-2. PubMed ID: 10076594
    [No Abstract]   [Full Text] [Related]  

  • 54. Activity of rifapentine against Mycobacterium avium infection in beige mice.
    Klemens SP; Cynamon MH
    J Antimicrob Chemother; 1992 May; 29(5):555-61. PubMed ID: 1624393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protein binding of rifapentine and its 25-desacetyl metabolite in patients with pulmonary tuberculosis.
    Egelund EF; Weiner M; Singh RP; Prihoda TJ; Gelfond JA; Derendorf H; Mac Kenzie WR; Peloquin CA
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4904-10. PubMed ID: 24841270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-performance liquid chromatography assay of rifapentine in human serum.
    He X; Wang J; Liu X; Chen X
    J Chromatogr B Biomed Appl; 1996 Jun; 681(2):412-5. PubMed ID: 8811456
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of activities of rifapentine and rifampin against Mycobacterium tuberculosis residing in human macrophages.
    Mor N; Simon B; Mezo N; Heifets L
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2073-7. PubMed ID: 8540718
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Murine pharmacokinetics of rifapentine delivered as an inhalable dry powder.
    Chan JG; Tyne AS; Pang A; McLachlan AJ; Perera V; Chan JC; Britton WJ; Chan HK; Duke CC; Young PM; Traini D
    Int J Antimicrob Agents; 2015 Mar; 45(3):319-23. PubMed ID: 25554469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of rifapentine: the way ahead.
    Mitchison DA
    Int J Tuberc Lung Dis; 1998 Aug; 2(8):612-5. PubMed ID: 9712273
    [No Abstract]   [Full Text] [Related]  

  • 60. The pharmacokinetics and pharmacodynamics of rifampicin in adults and children in relation to the dosage recommended for children.
    Donald PR; Maritz JS; Diacon AH
    Tuberculosis (Edinb); 2011 May; 91(3):196-207. PubMed ID: 21429802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.